Cancer Research UK

Indonesian and Scottish flags
#Cancer Research UK #Collaboration #Indonesia #Oncology #Scotland

Indonesia-Scotland cancer research partnership signed

The Ministry of Health of the Republic of Indonesia and the CRUK Scotland Institute have entered into a landmark partnership to advance cancer research, build capacity in cancer care, and support evidence-based health policies through the signing of a Memorandum of Understanding (MoU).  Dr Susanti Susanti, an… Read More

#Cancer Research #News

X-ray showing colon cancer
#Bowel cancer #Cancer Research UK #Colorectal cancer #Oncology #Personalised medicine

CRUK commits £5.5m to transform bowel cancer treatment

Cancer Research UK and partners have committed £5.5 ($7.1) million in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.  The CRC-STARS initiative will bring together over 40 research experts from across the UK, Spain, Italy and… Read More

#Cancer Research #News

#Cancer Research UK #Gene mutation #Genetics / genomics #Oncology #Paediatrics #The Institute of Cancer Research

International team unlocks the genetic secrets of neuroblastoma

A team of international researchers have secured £1.5 ($1.9) million funding from Cancer Research UK (CRUK) to study the genetic secrets of childhood cancer neuroblastoma.  The project will be led by scientists at the University of Sheffield, alongside colleagues from The Institute of Cancer Research (ICR), Kings… Read More

#Cancer Research #News #Trending News

Two scientists working in a research laboratory
#Cancer Research UK #Oncology #Peptides #Phase II trial #Rare cancers

UK-Norwegian collaboration to trial peptide for rare cancer

Cancer Research UK, Cytovation and the Norwegian Cancer Society have signed an agreement to bring Cytovation’s lead asset, CY-101, into a multi-national Phase II clinical trial for patients with adrenocortical carcinoma (ACC).  CY-101, developed by Cytovation, is a synthetic peptide with a dual function. It selectively targets and destroys cancer… Read More

#Business & Investment #Cancer Research #News

Monoclonal antibody
#Cancer Research UK #Clinical trial #Monoclonal antibodies #Oncology #UCB

Monoclonal antibody targets HLA-G in advanced cancers

A new clinical trial has launched to assess monoclonal antibody UCB4594 in people with advanced cancers. The first site for the study has opened at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie NHS Foundation Trust (The… Read More

#Cancer Research #News

Breast Cancer Awareness Month
#Breast cancer #Cancer research #Cancer Research UK #Cancer therapeutics #Oncology

How close is a cure for breast cancer?

This Breast Cancer Awareness Month, Diana Spencer takes a look at the current situation and the new therapies on the horizon. Breast cancer is the most common cancer globally, with around 2.3 million new cases every year, according to data from the World Health Organization (WHO). It represents one in… Read More

#Cancer Research #Editor's Choice #Exclusive Content

#Brain cancer #Cancer Research UK #Funding #Oncology #Paediatrics

£3m boost to paediatric brain cancer research

Experts from Cancer Research UK Children’s Brain Tumour Centre of Excellence in Cambridge, UK are set to share around £3.2 ($4.2) million to find and test better and less toxic ways to treat children’s brain tumours. The funding announcement comes during Childhood Cancer Awareness Month. Read More

#Cancer Research #News

UK visa application
#Cancer Research UK #Life sciences #Politics #UK #UK government

Strict UK immigration rules hold back cancer research

The UK immigration system is making it much harder for the country’s research institutions to compete for international talent, says Cancer Research UK (CRUK). With their annual visa costs projected to rise by 44% in a single year, the organisation is calling on the new UK… Read More

#News #Trending News

#Bioprinting #Cancer research #Cancer Research Horizons #Cancer Research UK #Cell therapy #Data #Data management #Data security #Drug development #Drug discovery #Electronic Lab Notebooks (ELN) #Laboratory data #Oncology #Organ manufacturing #Start-ups #Tissue engineering

Podcast looks behind the scenes of the drug discovery industry

This is the latest episode of the free DDW narrated podcast, titled “A look behind the scenes of the drug discovery industry” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Going paperless – the move to electronic lab… Read More

#News

Image of the earth showing the UK and Scandinavia
#Cancer Research UK #Collaboration #Norwegian Cancer Society #Oncology

UK-Norway partnership to speed up cancer drug discovery

Cancer Research UK and the Norwegian Cancer Society (NCS) have announced a new multi-project strategic partnership to maximise the unique drug development capabilities of both countries. Under the partnership, NCS intends to share funding and expertise to accelerate the development of cancer drug candidates with the… Read More

#Cancer Research #News

#Artificial intelligence (AI) #Cancer Research UK #Oncology #Prostate cancer #University of East Anglia #University of Oxford

AI reveals prostate cancer is not just one disease

Research published in Cell Genomics has shown that prostate cancer includes two different subtypes of the disease, also known as evotypes. This discovery was made by using artificial intelligence (AI) to help unlock new discoveries about the evolution of prostate cancer and could lead to the… Read More

#Cancer Research #News #Trending News

#Cancer research #Cancer Research Horizons #Cancer Research UK #Collaboration #Guardant Health #Precision medicine

CRUK and Guardant collaborate on precision cancer drugs

Cancer Research UK (CRUK), Cancer Research Horizons, and precision oncology company Guardant Health have launched a collaboration to advance cancer treatment. The agreement will enable the parties to discuss opportunities for collaboration to support the charity’s research and clinical development activities, focusing primarily on its clinical trials run by its… Read More

#Business & Investment #Cancer Research #News

Scientist in laboratory
#Cancer research #Cancer Research UK #Collaboration #KWF Dutch Cancer Society #Oncology

UK-Dutch alliance to strengthen early clinical oncology research

Cancer Research UK and the KWF Dutch Cancer Society (KWF) have announced a new multi-project strategic partnership to advance promising therapeutic agents for cancer. Under the partnership, KWF intends to provide funding to enable the development of select early phase clinical programmes through Cancer Research UK’s Centre… Read More

#Cancer Research #News

EU flag
#Cancer Research UK #Drug research #Funding #Horizon Europe #Investment #UK

What’s on the horizon for UK drug discovery?

Editor Reece Armstrong provides an introduction to the Fall 2023 issue of Drug Discovery World. Find out more about the issue and how to read it. That this issue should feature a market report on the state of the United Kingdom’s drug discovery sector at the same time the country… Read More

#Exclusive Content #Opinion